Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

) Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Saved in:
Bibliographic Details
Main Authors TEUBER, Lene, SCHRODER GLAD, Sanne, SARVARY, Ian, GRON NORAGER, Niels, HAAHR GOULIAEV, Alex, STASI, Luigi Piero
Format Patent
LanguageEnglish
Published 25.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:) Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
Bibliography:Application Number: AU20200213282